Solution
iSEP-SEQ Workflow
Our CNASafe platform and iSEP-SEQ workflow provide a practical, portable, adaptable, and cost-effective solution for rapid pathogen identification. With validation completed on over 400 plasma samples and 20 sepsis patients, we’re all set for our 100-patient NHS pilot in January 2025. Our technology is protected by two patent families, with coverage in the UK, US, and pending in Europe.
Rapid Pathogen Detection
Natantis' diagnostics process is designed to deliver results in just six hours instead of 3-7 days with traditional methods, allowing healthcare professionals to swiftly identify the cause of infections and administer targeted treatments.
Enhanced Precision
Our advanced cell-free DNA extraction and real-time nanopore sequencing detect pathogens even when standard blood cultures fail.
Adaptability
Our solution can be adapted to diagnose a wide range of infectious pathogens including bacteria, virus, parasite, and fungi.